| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701790 | Journal of Thoracic Oncology | 2016 | 45 Pages |
Abstract
NKD2 is frequently methylated in human esophageal cancer, and the expression of NKD2 is regulated by promoter region methylation. NKD2 suppresses esophageal cancer progression by inhibiting Wnt signaling both in vitro and in vivo.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Baoping MD, PhD, Weili MD, Yongshuai MD, Meiying MS, Tao MD, Qimin MD, James G. MD, Guanglin MD, Mingzhou MD, PhD,